A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Insulin detemir
Sulodexide
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Sulodexide.
Insulin detemir
Fibrinolysin
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Fibrinolysin.
Insulin detemir
Ancrod
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Ancrod.
Insulin detemir
Desmoteplase
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Desmoteplase.
Insulin detemir
Ximelagatran
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Ximelagatran.
Insulin detemir
Dabigatran
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Dabigatran.
Insulin detemir
Monteplase
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Monteplase.
Insulin detemir
Triflusal
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Triflusal.
Insulin detemir
Cangrelor
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Cangrelor.
Insulin detemir
Semuloparin
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Semuloparin.
Insulin detemir
Prasugrel
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Prasugrel.
Insulin detemir
Beraprost
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Beraprost.
Insulin detemir
Defibrotide
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Defibrotide.
Insulin detemir
Coumarin
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Coumarin.
Insulin detemir
Vorapaxar
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Vorapaxar.
Insulin detemir
Caplacizumab
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Caplacizumab.
Insulin detemir
Pitolisant
The serum concentration of Levomilnacipran can be decreased when it is combined with Pitolisant.
Insulin detemir
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Levomilnacipran.
Insulin detemir
Mometasone furoate
The metabolism of Mometasone furoate can be decreased when combined with Levomilnacipran.
Insulin detemir
Fluticasone
The metabolism of Levomilnacipran can be decreased when combined with Fluticasone.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3